Novel therapeutic target identified for chronic kidney disease

by Leigh MacMillan

Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury. The findings, reported in The Journal of Clinical Investigation, identify a novel signaling pathway as a therapeutic target in chronic kidney disease progression. Read more from the VUMC Reporter.